FDA-Inspected Site

GenIbet Biopharmaceuticals

2 FDA inspections are on record for GenIbet Biopharmaceuticals in Oeiras, Portugal.

483· Form 483 issued

Oeiras, Portugal · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-01-21.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
13 Jan 2025 – 21 Jan 2025Biologics483View 483 →
23 Jan 2023 – 31 Jan 2023Biologics483On file

Observations on record

Form 483 observations cited at this site, most recent first.

21 Jan 2025
21 CFR 211.180(e)(2)

Items to cover on annual reviews

Cited by Unnee Ranjan, Burnell M Henry

21 Jan 2025
21 CFR 211.198(b)

Maintenance of Complaint File

Cited by Unnee Ranjan, Burnell M Henry

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind GenIbet Biopharmaceuticals' 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat